Riluzole Tablet
Product Images NDC 67877-286

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Riluzole (NDC 67877-286). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Riluzole Blister 50mg 10 Tab

Riluzole Blister 50mg 10 Tab
This appears to be the labeling information for Riluzole tablets, with details about the manufacturer, dosage, lot number, and expiration date. The text is not readable in the "Embossing Zone" section, which may contain important information that is embossed onto the tablet's surface.*
FDA Label Image

Riluzole Cart 50 140 Tab

Riluzole Cart 50 140 Tab
Description: Riluzole Tablets, USP - a drug with a strength of 140 1019, available in a package of 10 x 14 unit dose tablets used to treat conditions such as Resiron and Ascenn.*
FDA Label Image

Riluzole Cont 50 60 Tab

Riluzole Cont 50 60 Tab
Each Riluzole Tablet, USP contains 50g of rhuzde and is produced by Ascend Laboratories. The usual dosage is every 12 hours orally. The NDC number is 67877-286.60 and the tablets should be kept out of reach of children at a controlled room temperature between 20-25°C (58-77°F). The tablet is 50mg and should only be prescribed by a doctor. The manufacturer is Ao Lot L and the product is distributed by Ascend Laboratories, LLC. There are 60 tablets in each package. Some information is available about a label with UV varnish.*
FDA Label Image

Riluzole-fig-1 (Riluzole Fig 1)

Riluzole-fig-1 (Riluzole Fig 1)
This document appears to be displaying a graph or figure related to survival probability with two groups, one receiving a placebo and one receiving Riluzole 50 mg twice daily. The graph may be a Kaplan-Meier Survival Curve. No further information is available.*
FDA Label Image

Riluzole-fig-2 (Riluzole Fig 2)

FDA Label Image

Riluzole-st (Riluzole St)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.